modipafant has been researched along with isbogrel in 2 studies
| Studies (modipafant) | Trials (modipafant) | Recent Studies (post-2010) (modipafant) | Studies (isbogrel) | Trials (isbogrel) | Recent Studies (post-2010) (isbogrel) |
|---|---|---|---|---|---|
| 6 | 0 | 0 | 12 | 0 | 3 |
| 6 | 0 | 0 | 31 | 1 | 0 |
| Protein | Taxonomy | modipafant (IC50) | isbogrel (IC50) |
|---|---|---|---|
| Thromboxane-A synthase | Homo sapiens (human) | 0.0222 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, M; Inada, H; Sano, T; Seki, T; Shimizu, K; Takahama, A | 2 |
2 other study(ies) available for modipafant and isbogrel
| Article | Year |
|---|---|
Approach to dual-acting platelet activating factor (PAF) receptor antagonist/thromboxane synthase inhibitor (TxSI) based on the link of PAF antagonists and TxSIs.
Topics: Animals; Drug Design; Enzyme Inhibitors; Humans; In Vitro Techniques; Indicators and Reagents; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Rabbits; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Structure-Activity Relationship; Thromboxane-A Synthase | 2002 |
Novel agents combining platelet activating factor (PAF) receptor antagonist with thromboxane synthase inhibitor (TxSI).
Topics: Animals; Azepines; Enzyme Inhibitors; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Rats; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Structure-Activity Relationship; Thiophenes; Thromboxane-A Synthase | 2002 |